Dr. Erin Meier Baskharoun, MD

Dr. Baskharoun practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Baskharoun's NPI, 1194254128, was assigned on June 4, 2017. Dr. Baskharoun graduated from American University of the Caribbean School of Medicine in 2017. Dr. Baskharoun holds New York license 306457.

Dr. Baskharoun's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Baskharoun's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Baskharoun is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Baskharoun to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baskharoun practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Baskharoun's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Baskharoun is licensed in New York.

CMS data shows 1,667 Medicare services from Dr. Baskharoun across 23 procedure codes in 2024, for 627 Medicare patients. Medicare paid $139,582 for them.

CMS counts 627 Medicare patients who saw Dr. Baskharoun in 2024. The largest group is 75 to 84, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baskharoun's median patient age at 68, with 46% women.

In 2024, Dr. Baskharoun wrote 741 Medicare Part D claims for 147 patients. 50% of them were for generic drugs. CMS names the drug for 604 of them, across 19 drugs with 11 or more claims each, at $803,131 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Baskharoun for performance year 2024, reported as part of a group. Dr. Baskharoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baskharoun as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Baskharoun from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.

Dr. Baskharoun graduated from American University of the Caribbean School of Medicine in 2017.